Rheumatrex /00113801/


Indications and Reactions:

Role Indications Reactions
Secondary
Rheumatoid Arthritis 65.3%
Osteoporosis 9.3%
Hypothyroidism 3.9%
Pain 3.9%
Analgesic Therapy 3.5%
Product Used For Unknown Indication 2.7%
Antiinflammatory Therapy 2.3%
Prophylaxis 1.9%
Gastritis 1.5%
Hyperlipidaemia 1.5%
Antibiotic Prophylaxis 1.2%
Antiviral Prophylaxis 1.2%
Constipation 0.4%
Gastritis Prophylaxis 0.4%
Hypertension 0.4%
Hyperuricaemia 0.4%
Thyroid Disorder 0.4%
Aspartate Aminotransferase Increased 20.0%
Intestinal Obstruction 10.0%
Gamma-glutamyltransferase Increased 8.0%
Large Intestine Perforation 8.0%
Diffuse Large B-cell Lymphoma 6.0%
Intentional Drug Misuse 6.0%
Mitral Valve Incompetence 6.0%
Pneumonia 6.0%
Interstitial Lung Disease 4.0%
Rheumatoid Arthritis 4.0%
Tubulointerstitial Nephritis 4.0%
Breast Cancer 2.0%
Colon Cancer 2.0%
Drug Effect Decreased 2.0%
Gastric Cancer 2.0%
Hepatic Function Abnormal 2.0%
Inguinal Hernia 2.0%
Leukoencephalopathy 2.0%
Lung Neoplasm Malignant 2.0%
Lymphoma 2.0%
Concomitant
Rheumatoid Arthritis 54.0%
Prophylaxis 11.3%
Hypertension 6.7%
Seronegative Arthritis 4.2%
Arthritis 4.0%
Product Used For Unknown Indication 3.3%
Osteoporosis 3.1%
Insomnia 2.7%
Sjogren's Syndrome 1.9%
Pain 1.3%
Tuberculin Test Positive 1.3%
Gastritis Prophylaxis 1.0%
Bronchitis 0.8%
Constipation 0.8%
Drug Detoxification 0.8%
Gastrooesophageal Reflux Disease 0.8%
Rhinitis Allergic 0.6%
Diabetes Mellitus 0.4%
Dizziness 0.4%
Eczema 0.4%
Reflux Oesophagitis 16.4%
Vasculitis Necrotising 13.7%
Nephritis 8.2%
Rash 8.2%
Septic Shock 8.2%
Aspartate Aminotransferase Increased 5.5%
Trigger Finger 5.5%
Subarachnoid Haemorrhage 4.1%
Vomiting 4.1%
White Blood Cell Count Decreased 4.1%
Bladder Cancer Recurrent 2.7%
Intentional Drug Misuse 2.7%
Malignant Neoplasm Progression 2.7%
Nasopharyngitis 2.7%
Nephrotic Syndrome 2.7%
Road Traffic Accident 2.7%
Breast Cancer 1.4%
Deep Vein Thrombosis 1.4%
Forearm Fracture 1.4%
Hepatic Enzyme Increased 1.4%

Drug Data